Pharm-Olam's response to COVID-19 from CEO Rob Davie, PhD. Read Here

Request a Proposal  

Allergic Rhinitis

An Allergy Case Study

Read the Case Study

About the Case Study

Allergic rhinitis is a global health problem affecting between 10% and 25% of the worldwide population. In the United States, the number of allergy sufferers is over 40 million people, 25-30 million of which suffer from allergic rhinitis. In the United Kingdom, the prevalence of allergic rhinitis is 16%, Denmark is 19%, and Germany between 13% and 17%. In different regions of the Russian Federation, the prevalence of allergic rhinitis ranges from 12.7% to 24%. The condition affects both children and adults, in both sexes. The highest prevalence of allergic rhinitis is observed in ecologically unfavorable regions. For instance, allergic rhinitis occupies more than 50% in the overall allergy prevalence among the population exposed to chemical and radiation factors.

Sites & Locations:

25+ in Eastern and Western Europe

Services Provided:

  • Regulatory
  • Project Management
  • Pharmacovigilance
  • Medical Monitoring
  • Medical Writing
  • Statistics
  • Quality Assurance

 

How can we help you create a healthier world?

Talk to one of our experts today.

Please choose one.

Contact Us